[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.

[FETV=김창수 기자] Celltrion announced on the 2nd (local time) that the European Medicines Agency has begun a review process to present expert opinions to European countries that want to introduce the Corona 19 antibody treatment Rekyrona early. GC Green Cross announced on the 3rd that it will ship’Hunterase ICV’, the world’s first severe hunter syndrome treatment, to Japan. Hyundai Pharm held the 2021 International Peptide Cosmetics Symposium at the head office of A&Pep, with Hyundai Pharm CEO Sang-jun Lee and A&Pep CEO Cha Sang-ju attending.

◆ Celltrion’Recyrona’ initiates emergency use review prior to product approval by the European Medicines Agency

On the 2nd (local time) of Celltrion, the European Medicines Agency (EMA) presented its expert opinion to European countries that want to introduce the Corona 19 antibody treatment Rekirona (development name: CT-P59, ingredient name: Regdanvimab) early. It said that it has undertaken a review process for the company.

This review is a separate procedure from the rolling review, which began on February 24 (local time). In order for individual European national quarantine authorities in urgent need of introduction of Rekirona to make a decision to introduce them through the Compassionate Use Program, etc., even before the EMA item is approved, a group of experts under the CHMP under the EMA It is intended to present a scientific opinion on whether it can be used or not.

◆ GC Green Cross starts exporting’Hunterase ICV’ to Japan

GC Green Cross begins shipping’Hunterase ICV (intracerebroventricular)’.

GC Green Cross announced on the 3rd that it will ship the world’s first severe-type Hunter syndrome treatment,’Hunterase ICV’ (product name: Futarase, Hüttaraゼ®脳室内注射液15mg) to Japan. It is an analysis that the market penetration has entered the visible range as the initial supply of goods has been made in a month or so after acquiring the Japanese item license in January.

‘Hunterase ICV’ is a treatment that directly administers drugs to the ventricle by inserting a device into the head. The existing intravenous formulation of drugs could not pass through the blood brain barrier (BBB) ​​and thus could not reach the’cerebral parenchyma’.

◆ Hyundai Pharm successfully hosts international peptide cosmetics symposium

Hyundai Pharm held the 2021 International Peptide Cosmetics Symposium at A&Pep headquarters.

The symposium was held with personnel from major affiliates including Hyundai Pharm Lee Sang-joon Lee and A&Pep CEO Cha Sang-ju, and was broadcast live through the Hyundai Pharm’s YouTube channel.

Academic professors, executives and staff members of Hyundai Pharm, and employees of A&Pep’s Peptide Research Institute participated and shared various research results and achievements on peptide cosmetics.

◆ USANA sponsors Seongnam FC official nutrition for 2 consecutive years

USANA Health Science Korea, a global cell science nutrition company, has signed an official nutrition sponsorship with Seongnam FC for the second consecutive year.

USANA will act as the official nutrition sponsor of Seongnam FC with the start of the K-League in the 2021 season as part of its sports sponsorship program’USANA Athletes’.

USANA will continue to provide various nutrition products including’Health Pack’, the company’s representative comprehensive vitamin and mineral product, so that the Seongnam FC athletes can perform at their best. I plan to visit my fans.

◆ I&NA launches’Ivory Care Pack’ service for newborns and mothers in postpartum care centers

In commemoration of the renewal opening of the pregnancy and childcare application’Ivory 3.0′, a pregnancy and childcare specialist, I&Na announced that it introduced the’Ivory Care Pack’ service, an exclusive service for newborns and mothers in the postpartum care center.

I&Na’s Ivory service is a service that allows mothers and families to view baby images from the newborn room through an application at about 190 postpartum care centers nationwide, starting with the’Bebecam’ service in 2016. Ivory has established itself as a representative mobile pregnancy and childcare platform that provides benefits to consumers through various shopping at the lowest price as well as information services for postpartum care centers.